A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine

Clinical trial NCT00471354 · COMPLETED

Trial details

NCT number: NCT00471354
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2007-04-01
Primary completion: 2008-11-01
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.